Glomerulonephritis is a rapidly evolving area of nephrology with major advances in disease pathogenesis and therapeutic targets leading to changes in clinical practice.

Join the Royal Society of Medicine for this two-day event, a collaboration between RSM Nephrology and Kidney Research UK Glomerulonephritis Clinical Study Group (GN CSG). It will explore the latest advances in the treatment and pathogenesis of primary and multisystem glomerular diseases. Through interactive lectures, case-based sessions, and panel discussions, this event will delve into the evolving clinical landscape and what it means for patient care.

Who should attend?

This meeting is a collaboration between clinicians, scientists, and healthcare professionals with an interest in glomerular diseases. 

By attending this meeting, you will:

• Build your understanding of the pathological mechanisms and therapeutic targets across primary glomerulonephritis, lupus, and vasculitis.
• Gain increased knowledge of therapeutic options for glomerular diseases.
• Enhanced insight into the evolving treatment landscape in daily practice and renal services.

Gain CPD points: Day 1 is worth 6 CPD points and Day 2 is worth 6 CPD points

Registration for this event closes at 1:00 am on Wednesday, 21 January 2026.